CNM Publications 2009 to Present

Selected Publications

Found 114 results
Author Title [ Type(Desc)] Year
Journal Article
Seo JWoong, Baek H, Mahakian LM, Kusunose J, Hamzah J, Ruoslahti E, Ferrara KW.  2014.  (64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque.. Bioconjug Chem. 25(2):231-9.
Yang WHo, Heithoff DM, Aziz PV, Haslund-Gourley B, Westman JS, Narisawa S, Pinkerton AB, Millán JLuis, Nizet V, Mahan MJ et al..  2018.  Accelerated Aging and Clearance of Host Anti-inflammatory Enzymes by Discrete Pathogens Fuels Sepsis. Cell Host & Microbe. 24(4)
Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth JD, Paulson JC, Taniguchi N.  2010.  Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.. J Biol Chem. 285(9):6515-21.
Hussain S, Joo J, Kang J, Kim B, Braun GB, She Z-G, Kim D, Mann AP, Mölder T, Teesalu T et al..  2018.  Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy.. Nat Biomed Eng. 2(2):95-103.
Simón-Gracia L, Scodeller P, Fuentes SSalazar, Vallejo VGómez, Ríos X, San Sebastián E, Sidorenko V, Di Silvio D, Suck M, De Lorenzi F et al..  2018.  Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice.. Oncotarget. 9(27):18682-18697.
Haspel N, Zanuy D, Nussinov R, Teesalu T, Ruoslahti E, Alemán C.  2011.  Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach.. Biochemistry. 50(10):1755-62.
Park J-H, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ.  2009.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications.. Nat Mater. 8(4):331-6.
Sturgill ER, Aoki K, Lopez PHH, Colacurcio D, Vajn K, Lorenzini I, Majić S, Yang WHo, Heffer M, Tiemeyer M et al..  2012.  Biosynthesis of the major brain gangliosides GD1a and GT1b.. Glycobiology. 22(10):1289-301.
Lingasamy P, Tobi A, Haugas M, Hunt H, Paiste P, Asser T, Rätsep T, Kotamraju VRamana, Bjerkvig R, Teesalu T.  2019.  Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery.. Biomaterials. 219:119373.
Jenning S, Pham T, Ireland SKale, Ruoslahti E, Biliran H.  2013.  Bit1 in anoikis resistance and tumor metastasis.. Cancer Lett. 333(2):147-51.
Fogal V, Sugahara KN, Ruoslahti E, Christian S.  2009.  Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.. Angiogenesis. 12(1):91-100.
Teesalu T, Sugahara KN, Kotamraju VRamana, Ruoslahti E.  2009.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.. Proc Natl Acad Sci U S A. 106(38):16157-62.
She Z-G, Liu X, Kotamraju VR, Ruoslahti E.  2014.  Clot-targeted micellar formulation improves anticoagulation efficacy of bivalirudin.. ACS Nano. 8(10):10139-49.
Sugahara KN, Teesalu T, Karmali PPrakash, Kotamraju VRamana, Agemy L, Greenwald DR, Ruoslahti E.  2010.  Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.. Science. 328(5981):1031-5.
Luni C, Marth JD, Doyle FJ.  2012.  Computational modeling of glucose transport in pancreatic β-cells identifies metabolic thresholds and therapeutic targets in diabetes.. PLoS One. 7(12):e53130.
Simberg D, Zhang W-M, Merkulov S, McCrae K, Park J-H, Sailor MJ, Ruoslahti E.  2009.  Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo.. J Control Release. 140(3):301-5.
Park J-H, von Maltzahn G, Xu MJue, Fogal V, Kotamraju VRamana, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanomaterial system to sensitize, target, and treat tumors.. Proc Natl Acad Sci U S A. 107(3):981-6.
Park J-H, von Maltzahn G, Ong LL, Centrone A, T Hatton A, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery.. Adv Mater. 22(8):880-5.
Yang WHo, Nussbaum C, Grewal PK, Marth JD, Sperandio M.  2012.  Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands.. Blood. 120(5):1015-26.
Wang H, Zhang W, Tang R, Hebbel RP, M Kowalska A, Zhang C, Marth JD, Fukuda M, Zhu C, Huo Y.  2009.  Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice.. Arterioscler Thromb Vasc Biol. 29(7):1053-9.
Wang H, Tang R, Zhang W, Amirikian K, Geng Z, Geng J, Hebbel RP, Xia L, Marth JD, Fukuda M et al..  2009.  Core2 1-6-N-glucosaminyltransferase-I is crucial for the formation of atherosclerotic lesions in apolipoprotein E-deficient mice.. Arterioscler Thromb Vasc Biol. 29(2):180-7.
Lee SHo, Yu S-Y, Nakayama J, Khoo K-H, Stone EL, Fukuda MN, Marth JD, Fukuda M.  2010.  Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.. J Biol Chem. 285(48):37683-92.
Ersoy SC, Heithoff DM, Barnes L, Tripp GK, House JK, Marth JD, Smith JW, Mahan MJ.  2017.  Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing.. EBioMedicine. 20:173-181.
Alberici L, Roth L, Sugahara KN, Agemy L, Kotamraju VR, Teesalu T, Bordignon C, Traversari C, Rizzardi G-P, Ruoslahti E.  2013.  De novo design of a tumor-penetrating peptide.. Cancer Res. 73(2):804-12.
Döring Y, Noels H, Mandl M, Kramp B, Neideck C, Lievens D, Drechsler M, Megens RTA, Tilstam PV, Langer M et al..  2014.  Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communication.. Circ Res. 114(6):976-81.